Introduction to asr1000rpx86-universalk9.V1612_1_CVE_2019_1649.SPA.bin Software

This critical security update package addresses CVE-2019-1649 – a high-risk vulnerability affecting Cisco ASR 1000 Series routers running IOS XE Release 16.12.x software. Designed as an emergency maintenance release, it provides targeted remediation for control plane resource exhaustion vulnerabilities while maintaining compatibility with existing network configurations.

​Core Specifications​​:

  • ​Release Date​​: Q4 2019 (Original security advisory timeframe)
  • ​Target Hardware​​: ASR1001/ASR1002-X/ASR1006-X chassis with RP3 processors
  • ​Security Compliance​​: FIPS 140-2 validated cryptographic modules
  • ​Package Type​​: Universal image with full K9 feature set (VPN/QoS/Security)

The “_V1612_1_CVE_2019_1649” designation confirms this is a security-specific build derived from IOS XE Gibraltar 16.12.1, prioritizing vulnerability remediation over feature updates.


Key Features and Improvements

1. Critical Vulnerability Mitigation

  • Patched CVE-2019-1649 through enhanced control plane queue management
  • Implemented strict rate-limiting for IPv6 neighbor discovery packets
  • Added real-time monitoring for BGP session resource consumption

2. Operational Stability Enhancements

  • 30% reduction in control-plane CPU spikes during DDoS attack simulations
  • Improved memory leak detection for OSPFv3 processes
  • Enhanced diagnostic logging for ESP200-X modules under high throughput

3. Security Framework Updates

  • Upgraded OpenSSL library to version 1.1.1k
  • Hardened SNMPv3 implementation against timing-based attacks
  • Extended Secure Boot validation for third-party service modules

Compatibility and Requirements

Component Minimum Requirement Recommended Configuration
Route Processor ASR1000-RP2 (32GB DRAM) ASR1000-RP3 (64GB DRAM)
ESP Module ESP100 (100G throughput) ESP200-X (400G throughput)
ROMmon Version 16.9(5r) 16.12(3r) with Secure Boot
Chassis ASR1002-X ASR1006-X with redundant PSUs

​Critical Compatibility Notes​​:

  1. Requires Cisco DNA Center v2.3.5+ for automated deployment
  2. Incompatible with SPA cards using FPGA versions below 20191215
  3. Mandatory CPLD upgrade to version 20191215 for RP3 modules

Verified Download & Enterprise Support

This security-critical update is available through:

  1. Cisco Software Center (Valid service contract required)
  2. TAC Emergency Access Portal for critical infrastructure operators
  3. Enterprise License Manager for multi-device deployments

Network administrators can obtain verified copies via IOSHub.net, offering:

  • SHA-384 checksum validation (d4e6f3d4e55…c7b3) for file integrity
  • Encrypted multi-thread downloads (AES-256-GCM)
  • Pre-deployment configuration audit tools

​Security Advisory Compliance​​:

  • 24/7 TAC Access with 1-hour SLA ($1,500/incident)
  • Vulnerability Impact Analysis ($2,000/report)
  • FIPS 140-2 Compliance Certification

Note: Always verify against Cisco’s official security advisory (cisco-sa-20190213-asr1000-rce) before deployment. Unauthorized distribution violates Cisco EULA Section 14.3

​References​
: Cisco ASR 1000 Series Security Configuration Guide
: CVE-2019-1649 Technical Impact Analysis
: IOS XE Gibraltar 16.12.x Release Notes


This article synthesizes critical security updates from Cisco’s advisories and hardware compatibility requirements, providing network engineers with actionable intelligence for securing ASR 1000 Series infrastructure against CVE-2019-1649 exploits. The “asr1000rpx86-universalk9.V1612_1_CVE_2019_1649.SPA.bin” package represents Cisco’s rapid response to critical infrastructure threats while maintaining operational stability in enterprise routing environments.

Contact us to Get Download Link Statement: All articles on this site, unless otherwise specified or marked, are original content published by this site. Any individual or organization is prohibited from copying, plagiarizing, collecting, or publishing the content of this site to any website, book or other media platform without the consent of this site. If the content of this site infringes on the legitimate rights and interests of the original author, please contact us for resolution.